Enjoy complimentary customisation on priority with our Enterprise License!
The ligases enzyme market share is expected to increase by USD 5.15 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 11.05%.
This ligases enzyme market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers ligases enzyme market segmentation by source (microorganism, animal, and plant) and geography (North America, Europe, Asia, and ROW). The ligases enzyme market report also offers information on several market vendors, including Agilent Technologies Inc., ArcticZymes Technologies ASA, BASF SE, Merck KGaA, New England Biolabs Inc., Novo Holdings AS, Promega Corp., QIAGEN NV, Takara Bio Inc., and Thermo Fisher Scientific Inc. among others.
Download the Free Report Sample to Unlock the Ligases Enzyme Market Size for the Forecast Period and Other Important Statistics
The growing need for ligases in disease treatment is notably driving the ligases enzyme market growth, although factors such as limitations associated with ligases enzymes may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the ligases enzyme industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.
Key Ligases Enzyme Market Driver
One of the key factors driving growth in the ligases enzyme market is the growing need for ligases in disease treatment. In recent years, the increasing prevalence of chronic diseases, such as cancer, among individuals is fueling the demand for new treatment methods to offer better patient care. The incidence of infections caused by pathogens such as bacteria, viruses, fungi, and parasites is increasing, resulting in infections such as hepatitis, herpes, urinary tract infections, and bladder infections. The increasing incidence of infectious diseases and genetic disorders leads researchers and scientists to opt for ligases enzymes to diagnose and treat various infections. Researchers are increasingly focusing on molecular biology due to its high impact on diagnosing and treating diseases using gene therapy. The increase in the prevalence of chronic and infectious diseases, coupled with the rising demand for the treatment of infectious diseases and genetic disorders using ligases enzyme, is expected to drive the growth of the global ligases enzyme market.
Key Ligases Enzyme Market Trend
The usage of qPCR and digital PCR (dPCR) systems is another factor supporting the ligases enzyme market share growth. PCR and dPCR involve using a thermostable ligase enzyme to join two probes or molecules together. This technology has a wide range of applications in diagnostic research. This includes human genetic testing, infectious disease testing, and pathogen detection. The increasing prevalence of chronic diseases infections caused by pathogens such as bacteria, viruses, fungi, and parasites led to rapid technological advancements in the development of qPCR and dPCR systems. This has led to high demand for ligases enzymes. To cater to this market demand, prominent vendors have launched advanced ligases enzymes to develop qPCR and dPCR kits. The demand for high-quality ligases enzymes from assay developers around the globe is expected to increase. These market trends will positively impact the growth of the global ligases enzyme market.
Key Ligases Enzyme Market Challenge
The limitations associated with ligases enzymes will be a major challenge for the ligases enzyme market during the forecast period. Ligases enzymes vary in their ability to repair nicks or breaks, link vectors and inserts, join fragments, and circularize double-stranded DNA (dsDNA). The accuracy and specificity of ligation depend on ligase selection and optimization of reaction conditions. Certain NAD-dependent thermostable DNA ligase, which is utilized in vitro, can ligate only a limited number of nicks. Furthermore, they have negligible activity on short cohesive and blunt substrates in end-joining reactions. Due to these limitations, they are not suitable for various applications. These limitations can lead to lesser usage of these ligases enzymes and such market challenges can negatively affect the growth of the global ligases enzyme market.
This ligases enzyme market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.
Technavio categorizes the global ligases enzyme market as a part of the global biotechnology market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the ligases enzyme market during the forecast period.
The report analyzes the market's competitive landscape and offers information on several market vendors, including:
This statistical study of the ligases enzyme market encompasses successful business strategies deployed by the key vendors. The ligases enzyme market is fragmented and the vendors are deploying organic and inorganic growth strategies to compete in the market.
ArcticZymes Technologies ASA - The company offers products such as T4 DNA Ligase.
To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
The ligases enzyme market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.
Our report provides extensive information on the value chain analysis for the ligases enzyme market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chains is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.
The value chain of the biotechnology market includes the following core components:
The report has further elucidated on other innovative approaches being followed by manufacturers to ensure a sustainable market presence.
For more insights on the market share of various regions Request for a FREE sample now!
39% of the market's growth will originate from North America during the forecast period. The US is the key market for ligases enzymes in North America. Market growth in this region will be faster than the growth of the market in the European, and ROW regions.
The presence of many vendors that offer ligases enzymes will facilitate the ligases enzyme market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.
COVID Impact and Recovery Analysis
In 2020, the COVID-19 pandemic positively impacted the regional ligases enzyme market. There was an increased demand for ligases enzymes from biotechnology and pharmaceutical companies, hospitals and diagnostic centers, and academic institutes and research organizations. Since the outbreak of the COVID-19 pandemic in March 2020, the US government has provided grants to various research institutes to conduct studies regarding the development of COVID-19 diagnostic kits. This includes the usage of ligases enzymes for the development of these kits.
To gain further insights on the market contribution of various segments Request for a FREE sample
The ligases enzyme market share growth by the microorganism segment will be significant during the forecast period. The market segment is expected to witness growth, owing to the wide range of applications of ligases enzymes sourced from microorganisms.
This report provides an accurate prediction of the contribution of all the segments to the growth of the ligases enzyme market size and actionable market insights on post COVID-19 impact on each segment.
Enzymes market - The market share should rise by USD 2.74 billion from 2022 to 2026 at a CAGR of 5.36%.
Speciality Enzymes market - The market size is expected to grow by $ 691.14 mn and record a CAGR of 5% during 2020-2024.
Ligases Enzyme Market Scope |
|
Report Coverage |
Details |
Page number |
120 |
Base year |
2021 |
Forecast period |
2022-2026 |
Growth momentum & CAGR |
Accelerate at a CAGR of 11.05% |
Market growth 2022-2026 |
$ 5.15 billion |
Market structure |
Fragmented |
YoY growth (%) |
10.47 |
Regional analysis |
North America, Europe, Asia, and ROW |
Performing market contribution |
North America at 39% |
Key consumer countries |
US, Germany, UK, China, and Japan |
Competitive landscape |
Leading companies, Competitive strategies, Consumer engagement scope |
Key companies profiled |
Agilent Technologies Inc., ArcticZymes Technologies ASA, BASF SE, Merck KGaA, New England Biolabs Inc., Novo Holdings AS, Promega Corp., QIAGEN NV, Takara Bio Inc., and Thermo Fisher Scientific Inc. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this report to meet your requirements. Get in touch
***1. Executive Summary
**1.1 Market Overview
*Exhibit 01: Key Finding 1
*Exhibit 02: Key Finding 2
*Exhibit 03: Key Finding 3
*Exhibit 04: Key Finding 5
*Exhibit 05: Key Finding 6
*Exhibit 06: Key Finding 7
*Exhibit 07: Key Finding 8
***2. Market Landscape
**2.1 Market ecosystem
*2.1.1 Parent Market
*Exhibit 08 Parent market
*Exhibit 09: Market characteristics
**2.2 Value Chain Analysis
*Exhibit 10: Value Chain Analysis: Biotechnology
*2.2.1 Research and Development (R&D)– Drug discovery
*2.2.2 Integration and product development
*2.2.3 Manufacturing
*2.2.4 Transportation and logistics
*2.2.5 Marketing and sales
*2.2.6 Support services
*2.2.7 Innovation
***3. Market Sizing
**3.1 Market definition
*Exhibit 11: Offerings of vendors included in the market definition
**3.2 Market segment analysis
*Exhibit 12: Market segments
**3.3 Market size 2021
**3.4 Market outlook: Forecast for 2021 - 2026
*3.4.1Estimating growth rates for emerging and high-growth markets
*3.4.2Estimating growth rates for mature markets
*Exhibit 13: Global - Market size and forecast 2021 - 2026 ($ million)
*Exhibit 14: Global market: Year-over-year growth 2021 - 2026 (%)
***4. Five Forces Analysis
**4.1 Five Forces Summary
*Exhibit 15: Five forces analysis 2021 - 2026
**4.2 Bargaining power of buyers
*Exhibit 16: Bargaining power of the buyer
**4.3 Bargaining power of suppliers
*Exhibit 17: Bargaining power of the supplier
**4.4 Threat of new entrants
*Exhibit 18: Threat of new entrants
**4.5 Threat of substitutes
*Exhibit 19: Threat of substitutes
**4.6 Threat of rivalry
*Exhibit 20: Threat of rivalry
**4.7 Market condition
*Exhibit 21: Market condition - Five forces 2021
***5. Market Segmentation by Source
**5.1 Market segments
*Exhibit 22: Source Market share 2021 - 2026 (%)
**5.2 Comparison by Source
*Exhibit 23: Comparison by Source
**5.3 Microorganism - Market size and forecast 2021-2026
*Exhibit 24: Microorganism - Market size and forecast 2021-2026 ($ million)
*Exhibit 25: Microorganism - Year-over-year growth 2021-2026 (%)
**5.4 Animal - Market size and forecast 2021-2026
*Exhibit 26: Animal - Market size and forecast 2021-2026 ($ million)
*Exhibit 27: Animal - Year-over-year growth 2021-2026 (%)
**5.5 Plant - Market size and forecast 2021-2026
*Exhibit 28: Plant - Market size and forecast 2021-2026 ($ million)
*Exhibit 29: Plant - Year-over-year growth 2021-2026 (%)
**5.6 Market opportunity by Source
*Exhibit 30: Market opportunity by Source
***6. Customer landscape
*Technavio’s customer landscape matrix comparing Drivers or price sensitivity, Adoption lifecycle, importance in customer price basket, Adoption rate and Key purchase criteria
**6.1 Overview
*Exhibit 31: Customer landscape
***7. Geographic Landscape
**7.1 Geographic segmentation
*Exhibit 32: Market share by geography 2021-2026 (%)
**7.2 Geographic comparison
*Exhibit 33: Geographic comparison
**7.3 North America - Market size and forecast 2021-2026
*Exhibit 34: North America - Market size and forecast 2021-2026($ million)
*Exhibit 35: North America - Year-over-year growth 2021-2026 (%)
**7.4 Europe- Market size and forecast 2021-2026
*Exhibit 36: Europe - Market size and forecast 2021-2026 ($ million)
*Exhibit 37: Europe - Year-over-year growth 2021-2026(%)
**7.6 Asia - Market size and forecast 2021-2026
*Exhibit 38: Asia - Market size and forecast 2021-2026 ($ million)
*Exhibit 39: Asia - Year-over-year growth 2021-2026 (%)
**7.7 ROW- Market size and forecast 2021-2026
*Exhibit 40: ROW - Market size and forecast 2021-2026 ($ million)
*Exhibit 41: ROW - Year-over-year growth 2021-2026 (%)
**7.8 Key leading countries
*Exhibit 42: Key leading countries
**7.8 Market opportunity by geography
*Exhibit 43: Market opportunity by geography ($ million)
***8. Drivers, Challenges, and Trends
**8.1 Market drivers
*8.1.1 Growing need for ligases in disease treatment
*8.1.2 Increased use of ligases enzyme by biotechnology and pharmaceutical companies
*8.1.3 Increase in R&D activities for sequencing applications
**8.2 Market challenges
*8.2.1 Limitations associated with ligases enzymes
*8.2.2 Handling and safety issues related to the enzyme
*8.2.3 Constraints pertaining to the chemical and physical properties of the enzyme
*Exhibit 44: Impact of drivers and challenges
**8.3 Market trends
*8.3.1 Usage in qPCR and digital PCR (dPCR) systems
*8.3.2 Use of ligases in protein engineering
*8.3.3 Technological advancements in the life sciences industry
***9. Vendor Landscape
**9.1 Overview
*Exhibit 45: Vendor landscape
**9.2 Landscape disruption
*Exhibit 46: Landscape disruption
*Exhibit 47: Industry Risk
**9.3 Competitive scenario
***10. Vendor Analysis
**10.1 Vendors covered
*Exhibit 48: Vendors covered
**10.2 Market positioning of vendors
*Exhibit 49: ?Market positioning of vendors?
**10.3 Agilent Technologies Inc.
*Exhibit 50: Agilent Technologies Inc. - Overview
*Exhibit 51: Agilent Technologies Inc. - Business segments
*Exhibit 52: Agilent Technologies Inc. - Key news
*Exhibit 53: Agilent Technologies Inc. - Key offerings
*Exhibit 54: Agilent Technologies Inc. - Segment focus
**10.4 ArcticZymes Technologies ASA
*Exhibit 55: ArcticZymes Technologies ASA - Overview
*Exhibit 56: ArcticZymes Technologies ASA - Business segments
*Exhibit 57: ArcticZymes Technologies ASA - Key news
*Exhibit 58: ArcticZymes Technologies ASA - Key offerings
*Exhibit 59: ArcticZymes Technologies ASA - Segment focus
**10.5 BASF SE
*Exhibit 60: BASF SE - Overview
*Exhibit 61: BASF SE - Business segments
*Exhibit 62: BASF SE - Key news
*Exhibit 63: BASF SE - Key offerings
*Exhibit 64: BASF SE - Segment focus
**10.6 Merck KGaA
*Exhibit 65: Merck KGaA - Overview
*Exhibit 66: Merck KGaA - Business segments
*Exhibit 67: Merck KGaA - Key news
*Exhibit 68: Merck KGaA - Key offerings
**10.7 New England Biolabs Inc.
*Exhibit 70: New England Biolabs Inc. - Overview
*Exhibit 71: New England Biolabs Inc. - Product and service
*Exhibit 72: New England Biolabs Inc - Key news
*Exhibit 73: New England Biolabs Inc. - Key offerings
**10.8 Novo Holdings AS
*Exhibit 74: Novo Holdings AS - Overview
*Exhibit 75: Novo Holdings AS - Product and service
*Exhibit 76: Novo Holdings AS - Key news
*Exhibit 77: Novo Holdings AS - Key offerings
**10.9 Promega Corp.
*Exhibit 78: Promega Corp. - Overview
*Exhibit 79: Promega Corp. - Product and service
*Exhibit 80: Promega Corp. - Key news
*Exhibit 81: Promega Corp. - Key offerings
**10.10 QIAGEN NV
*Exhibit 82: QIAGEN NV - Overview
*Exhibit 83: QIAGEN NV - Business segments
*Exhibit 84: QIAGEN NV - Key news
*Exhibit 85: QIAGEN NV - Key offerings
*Exhibit 86: QIAGEN NV - Segment focus
**10.11 Takara Bio Inc.
*Exhibit 87: Takara Bio Inc. - Overview
*Exhibit 88: Takara Bio Inc. - Business segments
*Exhibit 89: Takara Bio Inc. - Key offerings
*Exhibit 90: Takara Bio Inc. - Segment focus
**10.12 Thermo Fisher Scientific Inc.
*Exhibit 91: Thermo Fisher Scientific Inc. - Overview
*Exhibit 92: Thermo Fisher Scientific Inc. - Business segments
*Exhibit 93: Thermo Fisher Scientific Inc. - Key news
*Exhibit 94: Thermo Fisher Scientific Inc. - Key offerings
*Exhibit 95: Thermo Fisher Scientific Inc. - Segment focus
***11. Appendix
**11.1 Scope of the report
*11.1.1 ????Market definition
*11.1.2 ????Objectives
*11.1.3 ????Notes and caveats
**11.2 Currency conversion rates for US$
*Exhibit 96: ?Currency conversion rates for US$?
**11.3 Research Methodology
*Exhibit 97: ?Research Methodology
*Exhibit 98: ??Validation techniques employed for market sizing?
*Exhibit 99: ??Information sources
**11.4 List of abbreviations
*Exhibit 100: List of abbreviations
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.